ASX Share rice
Sun 09 May 2021 - 04:27:pm (Sydney)

AT1 Share Price

ATOMO DIAGNOSTICS LIMITEDAT1Class Pend

AT1 Company Information

Name:

Atomo Diagnostics Limited

Sector:

Healthcare

Industry:

Medical Devices

Address:

Level 2 Leichhardt NSW Australia 2040

Phone:

61 2 9099 4750

Founder, CEO, MD & Director:

Mr. John Michael Kelly

Chief Financial Officer:

Mr. William Edward Souter BCom, LLB (Adel), IPAA

Chief Operating Officer:

Mr. Mark Smith

Chief Commercial Officer:

Mr. Fabio Baglioni

Company Sec.:

Ms. Gillian Maria Nairn

Company Overview:

Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. The company has operations in Europe, Asia, Africa, and Central and South America. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.

AT1 Share Price Information

Shares Issued:

568.60M

Market Capitalisation:

$116.56M

Revenue (TTM):

$9.01M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$-0.0164

Profit Margin:

-1.0553

Operating Margin (TTM):

$-0.29

Return On Assets (TTM):

$-0.06

Return On Equity (TTM):

$-0.74

Quarterly Revenue Growth (YOY):

3.885

Gross Profit(TTM):

$3.42M

Diluted Earnings Per Share (TTM):

$-0.019

AT1 CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-1,993,141

Change To Liabilities:

$247.03K

Total Cashflow From Investing Activities:

$-1,993,141

Net Borrowings:

$5.80M

Net Income:

$-9,218,105

Total Cash From Operating Activities:

$-6,261,928

Depreciation:

$687.09K

Change To Inventory:

$-421,958

Change To Account Receivables:

$-2,941,119

Sale Purchase Of Stock:

$27.81M

Capital Expenditures:

$818.69K

AT1 Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-9,218,105

Net Income:

$-9,218,105

Gross Profit:

$-202,340

Operating Income:

$-7,640,361

Other Operating Expenses:

$-42,662

Interest Expense:

$5.29M

Total Revenue:

$1.97M

Cost Of Revenue:

$2.17M

AT1 Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$1.41M

Total Liabilities:

$663K

Total Stockholder Equity:

$36.04M

Other Current Liabilities:

$64.52K

Total Assets:

$36.70M

Common Stock:

$66.51M

Other Current Assets:

$1K

Retained Earnings:

$-32,329,359

Other Liabilities:

$105.02K

Cash:

$31.87M

Total Current Liabilities:

$1.51M

Property - Plant & Equipment:

$1.51M

Net Tangible Assets:

$32.96M

Total Current Assets:

$33.07M

Net Receivables:

$4.76M

Short-Term Investments:

$2.56M

Inventory:

$1.21M

Accounts Payable:

$0.93M

Short-Term Investments:

$2.56

Non Current Liabilities (Other):

$-1,000

Non Current Liabilities Total:

$85K

AT1 Share Price History

AT1 News

05 May, 2021
If you want to know who really controls Atomo Diagnostics Limited ( ASX:AT1 ), then you'll have to look at the makeup...
13 Mar, 2021
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
12 Jan, 2021
With the business potentially at an important milestone, we thought we'd take a closer look at Atomo Diagnostics...
13 Nov, 2020
If you want to know who really controls Atomo Diagnostics Limited (ASX:AT1), then you'll have to look at the makeup of...
14 Sep, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
16 Jul, 2020
Atomo Diagnostics Limited's (ASX:AT1): Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells...